Sensex 27371.84 245.27 0.9%
Nifty 8225.2 65.9 0.81%
BSE: 531739 | NSE: | ISIN: INE509C01026
Market Cap: [Rs.Cr.] 43.39 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Bulk Drugs
Management's Discussion and Analysis Report on the Business of the Company asapplicable and to the extent relevant is given below:
Overview & Operations of the Company
Gennex Laboratories Limited is in the business of Manufacturing of Bulk Drugs,Intermediates and Biotech Products. The Company is having a professionally managed team atevery stage of its operations.
Multipurpose and Multi product production facilities having ISO 9001:2008 and TUVCertificate 44 100 124194-E3, further the Company has obtained ISO 14001 and OSHAS 18000Certification.
- The Management depth and ability to manage client relationships.
- Enhanced presence in the international market.
Opportunities & Threats
Large number of Pharmaceutical companies losing their drug patents, thereby increasingthe scope of outsourcing to countries that offer a low cost manufacturing base.
The Pharma sector is expected to witness further consolidation by way of mergers andacquisitions this augurs for growth of the Industry. This would result in better pricerealization and growth.
The Indian Pharma Industry will have to meet the following challenges:
i. Multinational Companies are setting up large plants in India.
ii. Competition in the global market that offer low manufacturing base.
iii. Uncertainties on account of global socio economic environment.
Outlook for the Company
Your Company is on the verge of completion of the expansion plans undertaken. YourCompany has planned its business strategy taking the ground realities into account. TheCompany has introduced new products which are very competitive and beneficial to theCompany.
Risks and concerns
Any Government policy intervention or any change in the Pharma sector benefits andunforeseen adverse market conditions are issues of concern and may put pressure on theperformance of the Company.
Internal control system and their adequacy
The Company has Internal Control System which is adequate and commensurate with thesize of the Company.
Statement in this "Management Analysis Report" be considered to be forwardlooking statements with in the meaning of applicable securities laws or regulations.Actual result could differ materially from those expressed or implied. Important factorsthat could make a difference to the Company's operations include global and Indian demandsupply conditions, increased installed capacity, price bulk drugs and its availability,cyclical demands and pricing in the Company's market, changes in Government regulations,tax regimes, besides other factors such as litigations and labour negotiations.
|No Related Research Found|
|No Related Research Found|
U C Bhandari , Director
Y Ravinder Reddy , Director
Arihant Baid , Managing Director
Tiruvarur Muralidharan Gopalakrishnan , Whole-time Director
Company Head Office / Quarters:
AMI Computers (I) Ltd
60A & 60B,Chowringhee Road,2nd Floor,Kolkata - 700 020
Check whether Taxed / Tax free investment avenue is better for you
|Taxed Avenue||Tax-Free Avenue|
|Investment amount (Rs.)|
|Tenure of Investment (years)|
|Interest earned (% p.a)|
|Your tax bracket (%)|